Regulatory authorities have strict guidelines that study teams must follow to ensure all patients are treated fairly and safely, and that the trial’s potential benefits outweigh risks . Each study has a “protocol” that includes the necessary protections, and an independent body – who can end the trial at any time – regularly reviews the data.
